Advancing precision oncology: Insights from pan-cancer proteogenomic signatures

被引：0
|
作者：
Li, Yize
Terekhanova, Nadezhda V.
Wendl, Michael C.
Chen, Feng
Ding, Li
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5073
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
    Zhenhua Luo
    Weixu Wang
    Feng Li
    Zhou Songyang
    Xuyang Feng
    Changchang Xin
    Zhiming Dai
    Yuanyan Xiong
    Molecular Cancer, 18
  • [22] Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways
    Zhang, Yiqun
    Chen, Fengju
    Chandrashekar, Darshan S.
    Varambally, Sooryanarayana
    Creighton, Chad J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [23] Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes
    Luo, Zhenhua
    Wang, Weixu
    Li, Feng
    Zhou Songyang
    Feng, Xuyang
    Xin, Changchang
    Dai, Zhiming
    Xiong, Yuanyan
    MOLECULAR CANCER, 2019, 18 (1)
  • [24] A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
    Zhang, Yiqun
    Ng, Patrick Kwok-Shing
    Kucherlapati, Melanie
    Chen, Fengju
    Liu, Yuexin
    Tsang, Yiu Huen
    de Velasco, Guillermo
    Jeong, Kang Jin
    Akbani, Rehan
    Hadjipanayis, Angela
    Pantazi, Angeliki
    Bristow, Christopher A.
    Lee, Eunjung
    Mahadeshwar, Harshad S.
    Tang, Jiabin
    Zhang, Jianhua
    Yang, Lixing
    Seth, Sahil
    Lee, Semin
    Ren, Xiaojia
    Song, Xingzhi
    Sun, Huandong
    Seidman, Jonathan
    Luquette, Lovelace J.
    Xi, Ruibin
    Chin, Lynda
    Protopopov, Alexei
    Westbrook, Thomas F.
    Shelley, Carl Simon
    Choueiri, Toni K.
    Ittmann, Michael
    Van Waes, Carter
    Weinstein, John N.
    Liang, Han
    Henske, Elizabeth P.
    Godwin, Andrew K.
    Park, Peter J.
    Kucherlapati, Raju
    Scott, Kenneth L.
    Mills, Gordon B.
    Kwiatkowski, David J.
    Creighton, Chad J.
    CANCER CELL, 2017, 31 (06) : 820 - +
  • [25] Pan-cancer analysis of the interplay between mutational signatures and cellular signaling
    Hakobyan, Anna
    Meyenberg, Mathilde
    Vardazaryan, Nelli
    Hancock, Joel
    Vulliard, Loan
    Loizou, Joanna I.
    Menche, Jorg
    ISCIENCE, 2024, 27 (06)
  • [26] Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base
    Parry, Traci L.
    Gilmore, L. Anne
    Khamoui, Andy V.
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)
  • [27] Cardiovascular Complications of Pan-Cancer Therapies: The Need for Cardio-Oncology
    Chen, Mengjia
    Xue, Jianing
    Wang, Maoling
    Yang, Junyao
    Chen, Ting
    CANCERS, 2023, 15 (11)
  • [28] Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
    Huang, Da
    Shen, Jiayu
    Zhai, Lingyun
    Chen, Huanhuan
    Fei, Jing
    Zhu, Xiaoqing
    Zhou, Jianwei
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [29] ALDH2 as an immunological and prognostic biomarker: Insights from pan-cancer analysis
    Shen, Xiaorong
    Yan, Ziyi
    Huang, Yuanli
    Zhu, Qing
    Zhang, Guanghui
    Ci, Hongfei
    Wu, Qiong
    Wu, Ligao
    MEDICINE, 2024, 103 (16) : E37820
  • [30] Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer
    Lei, Jiali
    Luo, Jiangti
    Liu, Qian
    Wang, Xiaosheng
    CELLULAR ONCOLOGY, 2024, 47 (02) : 587 - 605
12345